ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

Clinical trial NCT02136914 · COMPLETED

Trial details

NCT number: NCT02136914
Sponsor: Adamas Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dyskinesia Levodopa Induced Dyskinesia (LID)Parkinson's Disease

Start date: 2014-05-01
Primary completion: 2015-12-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.